Mechanism of action of check FAQ anticonvulsants with www.selleckchem.com/products/Paclitaxel(Taxol).html respect to bipolar disorder Until the discovery of neuroleptics and lithium in the treatment

of BD, electroconvulsive therapy (ECT) was the only available-and still is the most effective- treatment of mania. The antimanic response is estimated to be approximately 80%11 Although the decisive cellular mechanisms for response remain speculative, it appears that with every Inhibitors,research,lifescience,medical application of ECT the seizure threshold increases. Thus, ECT has, paradoxically, an anticonvulsant effect. Interestingly, manic patients show an increase in seizure tiireshold with fading manic symptomatology.12 These observations may supply a clinical rationale for using anticonvulsants in the acute treatment of mania. When considering the cellular mode of action of anticonvulsants, we have to distinguish between three different Inhibitors,research,lifescience,medical levels: synaptic transmission, intracellular signaling, and, finally, gene activation. Following this hierarchy, we will first consider the impact of anticonvulsants on the metabolism and

the synaptic action of biogenic amines. GABA Both established mood stabilizers, CBZ and VPA, exhibit Inhibitors,research,lifescience,medical agonistic effects on the GABAergic system. CBZ is a positive modulator of the GABA A receptor that increases the GABA A receptor-mediated chloride current.13 VPA increases GABA release in different areas of the brain.14 This action of VPA was one of the supporting arguments leading to a GABA hypothesis of

BD.15-17 However, we are now facing a situation where we have to note that the most specific GABAergic anticonvulsants appear Inhibitors,research,lifescience,medical not to be as efficacious in BD as drugs with a wider range of Inhibitors,research,lifescience,medical action such as CBZ and VPA. A double-blind randomized trial of gabapentin18 could not support antimanic efficacy previously observed in open trials19, 20 and a first open trial for the y-aminobutyric acid plasma membrane transporter – 1 (GAT 1) inhibitor tiagabine also showed no benefit in manic patients.21 Another highly specific GABAergic compound, vigabatrine, is even suspected of inducing affective disorders and psychosis in epileptic Dacomitinib patients.22 Excitatory amino acids Inhibition of N-methyl-D-aspartate (NMDA) receptor-mediated currents have been reported for CBZ.23 In addition, a decrease in aspartate release was observed for VPA.24 As far as the new antiepileptic drugs are concerned, much thought has been given to the inhibition of glutamate and aspartate release by LTG.25, 26 However, this appears to be more an effect mediated by the blockade of sodium channels rather than a direct effect on synthesis and release of excitatory amino acids.